Search Results - "Sandler, H. M."

Ki-67 Staining Is a Strong Predictor of Distant Metastasis and Mortality for Men With Prostate Cancer Treated With Radiotherapy Plus Androgen Deprivation: Radiation Therapy Oncology Group Trial 92–02 by POLLACK, A, DESILVIO, M, HANKS, G. E, SANDLER, H. M, KHOR, L.-Y, LI, R, AL-SALEEM, T. I, HAMMOND, M. E, VENKATESAN, V, LAWTON, C. A, ROACH, M. III, SHIPLEY, W. U

“…The Ki-67 staining index (Ki67-SI) has been associated with prostate cancer patient outcome; however, few studies have involved radiotherapy (RT) -treated…”
Get full text

The evolution of chemotherapy for the treatment of prostate cancer by Quinn, D.I., Sandler, H.M., Horvath, L.G., Goldkorn, A., Eastham, J.A.

“…Chemotherapy has been explored as a treatment option for metastatic prostate cancer since the early 1980s. Docetaxel, a taxane chemotherapeutic, was approved…”
Get full text

Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer by Wei, John T, Dunn, Rodney L, Litwin, Mark S, Sandler, Howard M, Sanda, Martin G

“…Objectives. Health-related quality of life (HRQOL) is an increasingly important endpoint in prostate cancer care. However, pivotal issues that are not fully…”
Get full text

Radiation Therapy for Clinically Localized Prostate Cancer: A Multi-institutional Pooled Analysis by Shipley, William U, Thames, Howard D, Sandler, Howard M, Hanks, Gerald E, Zietman, Anthony L, Perez, Carlos A, Kuban, Deborah A, Hancock, Steven L, Smith, Cyndi D

“…CONTEXT Prostate-specific antigen (PSA) evaluation leads to the early detection of both prostate cancer and recurrences following primary treatment…”
Get full text

Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials by Roach, 3rd, Mack, Weinberg, V, Nash, M, Sandler, H M, McLaughlin, P W, Kattan, M W

“…Death from prostate cancer is usually preceded by metastases and it usually occurs in men with high risk disease who experienced biochemical failure with a…”
Get more information

Prostate Cancer Susceptibility Locus on Chromosome 1q: a Confirmatory Study by Cooney, Kathleen A., Huang, Li, Sandler, Howard M., Lange, Ethan, Lange, Kenneth, Miesfeldt, Susan, McCarthy, Jenifer D., Montie, James E., Oesterling, Joseph E.

“…Background: Recent recognition that a predisposition to prostate cancer can be inherited has led to a search for specific genes associated with the disease…”
Get full text

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406 by Michalski, J M, Purdy, J A, Winter, K, Roach, 3rd, M, Vijayakumar, S, Sandler, H M, Markoe, A M, Ritter, M A, Russell, K J, Sailer, S, Harms, W B, Perez, C A, Wilder, R B, Hanks, G E, Cox, J D

“…A prospective Phase I dose escalation study was conducted to determine the maximally-tolerated radiation dose in men treated with three-dimensional conformal…”
Get more information

Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study by Lee, S W, Fraass, B A, Marsh, L H, Herbort, K, Gebarski, S S, Martel, M K, Radany, E H, Lichter, A S, Sandler, H M

“…To analyze the failure patterns for patients with high-grade astrocytomas treated with high-dose conformal radiotherapy (CRT) using a quantitative technique to…”
Get more information

Influence of 3D-CRT pelvic irradiation on outcome in prostate cancer treated with external beam radiotherapy by Pan, C C, Kim, K Y, Taylor, J M G, McLaughlin, P W, Sandler, H M

“…The role of pelvic irradiation (PRT) in the treatment of prostate cancer remains unclear. We reviewed our institution's experience with three-dimensional…”
Get more information

What does postradiotherapy PSA nadir tell us about freedom from PSA failure and progression-free survival in patients with low and intermediate-risk localized prostate cancer? by DeWitt, K.D, Sandler, H.M, Weinberg, V, McLaughlin, P.W, Roach, M

“…To determine whether the post-external beam radiotherapy (RT) prostate-specific antigen nadir (nPSA) improves our ability to predict freedom from PSA failure,…”
Get full text

The effect of patient position and treatment technique in conformal treatment of prostate cancer by McLaughlin, P W, Wygoda, A, Sahijdak, W, Sandler, H M, Marsh, L, Roberson, P, Ten Haken, R K

“…The relative value of prone versus supine positioning and axial versus nonaxial beam arrangements in the treatment of prostate cancer remains controversial…”
Get more information

3D conformal radiation therapy (3DCRT) for high grade prostate cancer: a multi-institutional review by Fiveash, J B, Hanks, G, Roach, M, Wang, S, Vigneault, E, McLaughlin, P W, Sandler, H M

“…To evaluate the results of 3DCRT and the effect of higher than traditional doses in patients with high grade prostate cancer, we compiled data from three…”
Get more information

Prostate position late in the course of external beam therapy: patterns and predictors by Zellars, R C, Roberson, P L, Strawderman, M, Zhang, D, Sandler, H M, Ten Haken, R K, Osher, D, McLaughlin, P W

“…To examine prostate and seminal vesicles position late in the course of radiation therapy and to determine the effect and predictive value of the bladder and…”
Get more information

Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy by Sartor, C I, Strawderman, M H, Lin, X H, Kish, K E, McLaughlin, P W, Sandler, H M

“…A rising prostate specific antigen (PSA) following treatment for adenocarcinoma of the prostate indicates eventual clinical failure, but the rate of rise can…”
Get more information

Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa? by Fukunaga-Johnson, N, Lee, J H, Sandler, H M, Robertson, P, McNeil, E, Goldwein, J W

“…Craniospinal radiation (CSRT) followed by a boost to the entire posterior fossa (PF) is standard postoperative therapy for patients with medulloblastoma. A…”
Get more information

Malignant astrocytomas : focal tumor recurrence after focal external beam radiation therapy by LIANG, B. C, THORNTON, A. F, SANDLER, H. M, GREENBERG, H. S

“…Hochberg and Pruitt have reported glioblastomas recurring within 2 cm of the primary site in 90% of patients after whole-brain radiation therapy. They…”
Get full text

Results of 3D conformal radiotherapy in the treatment of localized prostate cancer by Fukunaga-Johnson, N, Sandler, H M, McLaughlin, P W, Strawderman, M S, Grijalva, K H, Kish, K E, Lichter, A S

“…3D conformal radiotherapy (3D CRT) has been shown to decrease acute morbidity in the treatment of prostate cancer. Therapeutic outcome and late morbidity data…”
Get more information

Dose-volume complication analysis for visual pathway structures of patients with advanced paranasal sinus tumors by Martel, M K, Sandler, H M, Cornblath, W T, Marsh, L H, Hazuka, M B, Roa, W H, Fraass, B A, Lichter, A S

“…The purpose of the present work was to relate dose and volume information to complication data for visual pathway structures in patients with advanced…”
Get more information

The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms by Thornton, Jr, A F, Sandler, H M, Ten Haken, R K, McShan, D L, Fraass, B A, La Vigne, M L, Yanke, B R

“…Results of the clinical experience gained since 1986 in the treatment planning of patients with brain neoplasms through integration of magnetic resonance…”
Get more information

Optimization and clinical use of multisegment intensity-modulated radiation therapy for high-dose conformal therapy by Fraass, Benedick A., Kessler, Marc L., McShan, Daniel L., Marsh, Lon H., Watson, Barbara A., Dusseau, Wendy J., Eisbruch, Avi, Sandler, Howard M., Lichter, Allen S.

“…Intensity-modulated radiation therapy (IMRT) may be performed with many different treatment delivery techniques. This article summarizes the clinical use and…”
Get full text